迪卡斯 DCTH 深 沪
等待开盘 10-21 09:30:00 美东时间
14.76
+0.390
+2.71%
华盛通- 最 高14.93
- 今 开14.46
- 成交量 29.42万股
- 最 低 14.405
- 昨 收 14.37
- 总市值 5.12亿
- 52周最高 17.42
- 市盈率 静 218.34
- 换手率 0.85%
- 52周最低 8.12
- 委 比 -93.70%
- 总股本 3469.88万
- 历史最高 9368800000.00
- 量 比 1.06
- 振 幅 3.65%
- 历史最低 2.25
- 每 手 1
- 风险率 2.54%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Delcath Systems Q2 2026 Earnings Call Transcript
Delcath Systems (NASDAQ:DCTH) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to...
10-06 17:31
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
BTIG Maintains Buy on Delcath Systems, Raises Price Target to $21
BTIG analyst Marie Thibault maintains Delcath Systems (NASDAQ:DCTH) with a Buy and raises the price target from $17 to $21.
08-07 02:40
Delcath Systems Q2 EPS $0.07 Beats $(0.09) Estimate, Sales $29.133M Beat $26.259M Estimate
Delcath Systems (NASDAQ:DCTH) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.09) by 177.78 percent. This is unchanged from the same period last year. The company reported quarterly sales of $29.133 million which beat the analyst consensus estimate of ...
08-06 20:03
Delcath Systems FY2026 Revenue expected to be more than $100.000M vs $104.070M Est
Delcath Systems (NASDAQ:DCTH) FY2026 Revenue expected to be more than $100.000M vs $104.070M Est
05-07 20:47
Delcath Systems' CHEMOSAT M-PHP Recognized As Recommended Liver-Directed Therapy For Metastatic Uveal Melanoma In 2026 ESMO–EURACAN Guidelines
Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on liver-directed cancer therapies, today announced that its proprietary CHEMOSAT® Hepatic Delivery System for Melphalan percutaneous
04-06 21:09
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
Delcath Systems shares are trading lower. The company reported Q4 financial results.
Delcath Systems shares are trading lower. The company reported Q4 financial res...
02-26 23:50
Delcath Systems FY2026 Total CHEMOSAT and HEPZATO KIT Revenue expected to be more than $100.000M vs $112.895M Est
Delcath Systems (NASDAQ:DCTH) FY2026 Total CHEMOSAT and HEPZATO KIT Revenue expected to be more than $100.000M vs $112.895M Est
02-26 22:18
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
